Cargando…

The Use of Novel Non-Vitamin K Antagonist Oral Anticoagulants Following Closure of the Left Atrial Appendage: Preliminary Results of Clinical Follow-Up

OBJECTIVE: The aim of this study was to investigate the safety and efficacy of using novel non-vitamin K antagonist oral anticoagulants (NOACs) for anticoagulation following left atrial appendage closure (LAAC). METHODS: A total of 70 patients with non-valvular atrial fibrillation (NVAF) were enroll...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Jing, Xu, Jian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7955747/ https://www.ncbi.nlm.nih.gov/pubmed/33727795 http://dx.doi.org/10.2147/DDDT.S293812

Ejemplares similares

Outcomes of left atrial appendage occlusion vs. non-vitamin K antagonist oral anticoagulants in atrial fibrillation
por: Ding, Wern Yew, et al.
Publicado: (2022)

Percutaneous Left Atrial Appendage Occlusion in Comparison to Non‐Vitamin K Antagonist Oral Anticoagulant Among Patients With Atrial Fibrillation
por: Noseworthy, Peter A., et al.
Publicado: (2022)

Cost-Effectiveness of Left Atrial Appendage Closure With the WATCHMAN Device Compared With Warfarin or Non–Vitamin K Antagonist Oral Anticoagulants for Secondary Prevention in Nonvalvular Atrial Fibrillation
por: Reddy, Vivek Y., et al.
Publicado: (2018)

Comparison of Left Atrial Appendage Occlusion versus Non-Vitamin-K Antagonist Oral Anticoagulation in High-Risk Atrial Fibrillation: An Update
por: Chen, Shaojie, et al.
Publicado: (2021)

Evaluation of left atrial remodelling following percutaneous left atrial appendage closure
por: Jalal, Zakaria, et al.
Publicado: (2017)

Optimal nonvitamin K antagonist oral anticoagulant therapy in a warfarin-sensitive patient after left atrial appendage closure: A case report
por: Shen, Long, et al.
Publicado: (2018)

Left Atrial Appendage Closure in Atrial Fibrillation: A World without Anticoagulation?
por: Contractor, Tahmeed, et al.
Publicado: (2011)

Left atrial appendage closure in atrial fibrillation patients with prior major bleeding or ineligible for oral anticoagulation
por: Wintgens, L. I. S., et al.
Publicado: (2019)

Left Atrial Appendage Closure: A Safe and Effective Alternative to Anticoagulation?
por: Infeld, Margaret M., et al.
Publicado: (2019)

The Safety and Efficacy of Standard-Dose versus Low-Dose Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation and Left Atrial Appendage Thrombus
por: Feng, Mingjun, et al.
Publicado: (2021)

Resolution of left atrial appendage thrombi: No difference between phenprocoumon and non‐vitamin K‐dependent oral antagonists
por: Biller, Katharina, et al.
Publicado: (2022)

Outcomes of cardiac surgery with left atrial appendage occlusion versus no Occlusion, direct oral Anticoagulants, and vitamin K Antagonists: A systematic review with Meta-analysis
por: Nso, Nso, et al.
Publicado: (2022)

Vitamin K Antagonists, Non–Vitamin K Antagonist Oral Anticoagulants, and Vascular Calcification in Patients with Atrial Fibrillation
por: Peeters, Frederique E. C. M., et al.
Publicado: (2018)

Recurrent Left Pleural Effusion Following Left Atrial Appendage Closure With the Watchman Device
por: Halaby, Rim, et al.
Publicado: (2020)

Left Atrial Appendage Closure Devices
por: Romero, Jorge, et al.
Publicado: (2014)

Transcatheter Left Atrial Appendage Closure
por: Wong, Gordon X., et al.
Publicado: (2023)

Left atrial appendage closure for atrial fibrillation in a patient with hypertrophic cardiomyopathy in whom long-term oral anticoagulation was not feasible
por: Kłopotowski, Mariusz, et al.
Publicado: (2019)

Clinical follow-up of left atrial appendage occlusion in patients with atrial fibrillation ineligible of oral anticoagulation treatment—a systematic review and meta-analysis
por: Labori, Frida, et al.
Publicado: (2021)

Oral Anticoagulation Use and Left Atrial Appendage Occlusion in LAAOS III
por: Connolly, Stuart J., et al.
Publicado: (2023)

Non-vitamin K antagonist oral anticoagulants in cancer patients with atrial fibrillation
por: Undas, Anetta, et al.
Publicado: (2020)

Case report: percutaneous closure of residual leak following left atrial appendage occlusion
por: Suradi, Hussam S, et al.
Publicado: (2020)

Pericardial effusion following percutaneous left atrial appendage closure using the LAmbre device
por: Yu, Yibo, et al.
Publicado: (2023)

Left Atrial Appendage Closure – The WATCHMAN Device
por: Akinapelli, Abhilash, et al.
Publicado: (2015)

Left atrial appendage closure: outcomes and challenges
por: Suradi, H. S., et al.
Publicado: (2016)

Surgical clip closure of the left atrial appendage
por: Rosati, Fabrizio, et al.
Publicado: (2021)

Periprocedural anticoagulation during left atrial ablation: interrupted and uninterrupted vitamin K-antagonists or uninterrupted novel anticoagulants
por: Brinkmeier-Theofanopoulou, Maria, et al.
Publicado: (2018)

Left atrial appendage perforation during appendage angiography treated by percutaneous left atrial appendage closure: a case report
por: Champagne, Catherine, et al.
Publicado: (2021)

Non-vitamin K antagonist oral anticoagulants in older and frail patients with atrial fibrillation
por: Giugliano, Robert P
Publicado: (2022)

Use of non-vitamin K antagonists oral anticoagulants in atrial fibrillation patients on dialysis
por: Li, Wenhao, et al.
Publicado: (2022)

Low-dose non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
por: Lee, Ki Hong, et al.
Publicado: (2023)

Low Dose of Direct Oral Anticoagulants after Left Atrial Appendage Occlusion
por: Cepas-Guillen, Pedro Luis, et al.
Publicado: (2021)

Is Left Atrial Appendage Occlusion Always Better than Direct Oral Anticoagulants?
por: Kim, Jun
Publicado: (2021)

Left Atrial Appendage Thrombus Formation Despite Continuous Non-Vitamin K Antagonist Oral Anticoagulant Therapy in Atrial Fibrillation Patients Undergoing Electrical Cardioversion or Catheter Ablation: A Comparison of Dabigatran and Rivaroxaban
por: Gorczyca, Iwona, et al.
Publicado: (2020)

Percutaneous left atrial appendage closure using the LAmbre device in patients with atrial fibrillation and left atrial appendage thrombus
por: Jin, Lu-Shen, et al.
Publicado: (2022)

Unroofed Coronary Sinus as Potential Cause of Ischemic Stroke Following Left Atrial Appendage Closure
por: Liu, Baoqiong, et al.
Publicado: (2023)

Direct oral anticoagulants compared to vitamin K antagonist for the management of left ventricular thrombus
por: Iqbal, Hansa, et al.
Publicado: (2020)

Assessment of non‐vitamin K antagonist oral anticoagulants for the management of left ventricular thrombus
por: Li, Shunhui, et al.
Publicado: (2021)

Incidentally detected accessory left atrial appendage in a patient being planned for left atrial appendage closure
por: Siddamsetti, Sisir, et al.
Publicado: (2021)

An updated meta-analysis of device related thrombus following left atrial appendage closure in patients with atrial fibrillation
por: Zhang, Song, et al.
Publicado: (2022)

Percutaneous closure of the left atrial appendage for secondary prevention of stroke in patients with atrial fibrillation and contraindications to chronic anticoagulant therapy
por: Lasek-Bal, Anetta, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_bs4vmjtkccpci4ccndbgnln25v